ING Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCE
MF
CC
AAM
PCM
FCM
PC
BBA
ING Group's ONCE Position: Q2 2019 in Review
ING Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 6,000 shares — an estimated $683K sold.
ING Group first reported a position in ONCE in Q1 2019 and held it in 1 quarter. The position peaked at $683K in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.
- ING Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- ING Group sold 6,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $683K.
- ING Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
- ING Group's Spark Therapeutics, Inc. Common Stock position peaked at $683K in Q1 2019.
- 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.
Based on ING Group's 13F filing for Q2 2019, filed 12 Aug 2019.